Doctor Pedro Marques

Faculty of Medicine University of Porto, Porto (Portugal)

Membership: HFA Member

Contributor content

$Effects of glucagon like peptide 1 receptor agonist initiation in patients with heart failure and reduced ejection fraction and implantable cardiac devices$

Presentation

Effects of glucagon like peptide 1 receptor agonist initiation in patients with heart failure and reduced ejection fraction and implantable cardiac devices

Presentation

Empagliflozin in acute heart failure with diuretic resistance: Clinical case and rationale for the DRIP-AHF1 trial

$Acute pulmonary oedema as clinical presentation of acute heart failure is associated with better prognosis in patients with reduced ejection fraction$

Presentation

Acute pulmonary oedema as clinical presentation of acute heart failure is associated with better prognosis in patients with reduced ejection fraction

Explore sponsored resources

Doctor Pedro Marques

Contributor content

Effects of glucagon like peptide 1 receptor agonist initiation in patients with heart failure and reduced ejection fraction and implantable cardiac devices

Empagliflozin in acute heart failure with diuretic resistance: Clinical case and rationale for the DRIP-AHF1 trial

Acute pulmonary oedema as clinical presentation of acute heart failure is associated with better prognosis in patients with reduced ejection fraction

ESC 365 is supported by